29176-44-1

Basic information

• Product Name: benzyl (2-((2-benzoyl-4-chlorophenyl)(methyl)amino)-2-oxoethyl)carbamate
• Synonyms: benzyl (2-((2-benzoyl-4-chlorophenyl)(methyl)amino)-2-oxoethyl)carbamate
• CAS NO: 29176-44-1
• Molecular Weight: 436.895
• Mol File: 29176-44-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: benzyl (2-((2-benzoyl-4-chlorophenyl)(methyl)amino)-2-oxoethyl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl (2-((2-benzoyl-4-chlorophenyl)(methyl)amino)-2-oxoethyl)carbamate(29176-44-1)
• EPA Substance Registry System: benzyl (2-((2-benzoyl-4-chlorophenyl)(methyl)amino)-2-oxoethyl)carbamate(29176-44-1)

Safety Data

• Hazardous Substances Data: 29176-44-1(Hazardous Substances Data)

Upstream product

• 15050-24-5 N-(benzyloxycarbonyl)glycyl chloride 
• 1022-13-5 5-chloro-2-(methylamino)benzophenone 
• 1138-80-3 N-(Benzyloxycarbonyl)glycine 

Downstream Products

• 60067-08-5 2-amino-N-(2-benzoyl-4-chlorophenyl)-N-methylacetamide hydrobromide 
• 439-14-5 diazepam 

Relevant articles and documents

THERAPEUTIC COMPOUNDS AND FORMULATIONS FOR INTRANASAL DELIVERY

Certain embodiments of the invention provide a formulation suitable for nasal administration comprising water, a prodrug of a therapeutic agent, and an enzyme that is suitable for intranasal conversion of the prodrug to the therapeutic agent, as well as methods of use thereof.